Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication
- 1 July 2016
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 118 (2) , 198-203
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Local Production of Fatty Acid–Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanismsObesity, 2014
- Adipocyte Lipid Chaperone aP2 Is a Secreted Adipokine Regulating Hepatic Glucose ProductionCell Metabolism, 2013
- The PCSK9 decadeJournal of Lipid Research, 2012
- PCSK9R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart DiseaseJACC, 2010
- PCSK9 Dominant Negative Mutant Results in Increased LDL Catabolic Rate and Familial HypobetalipoproteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Fatty acid-binding proteins: role in metabolic diseases and potential as drug targetsNature Reviews Drug Discovery, 2008
- Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2Nature, 2007
- Adipocyte Fatty Acid–Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic SyndromeClinical Chemistry, 2006
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003